Your browser doesn't support javascript.
loading
Impaired CaV1.2 inactivation reduces the efficacy of calcium channel blockers in the treatment of LQT8.
Bamgboye, Moradeke A; Traficante, Maria K; Owoyemi, Josiah; DiSilvestre, Deborah; Vieira, Daiana C O; Dick, Ivy E.
Afiliación
  • Bamgboye MA; Department of Physiology, University of Maryland, School of Medicine, Baltimore, MD, United States of America.
  • Traficante MK; Department of Physiology, University of Maryland, School of Medicine, Baltimore, MD, United States of America.
  • Owoyemi J; Department of Physiology, University of Maryland, School of Medicine, Baltimore, MD, United States of America.
  • DiSilvestre D; Department of Physiology, University of Maryland, School of Medicine, Baltimore, MD, United States of America.
  • Vieira DCO; Department of Physiology, University of Maryland, School of Medicine, Baltimore, MD, United States of America.
  • Dick IE; Department of Physiology, University of Maryland, School of Medicine, Baltimore, MD, United States of America. Electronic address: ied@som.umaryand.edu.
J Mol Cell Cardiol ; 173: 92-100, 2022 12.
Article en En | MEDLINE | ID: mdl-36272554
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de QT Prolongado / Bloqueadores de los Canales de Calcio Límite: Child, preschool / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de QT Prolongado / Bloqueadores de los Canales de Calcio Límite: Child, preschool / Humans Idioma: En Año: 2022 Tipo del documento: Article